Trexquant Investment LP purchased a new stake in shares of Spectranetics Corp (NASDAQ:SPNC) during the second quarter, Holdings Channel reports. The firm purchased 10,600 shares of the medical equipment provider’s stock, valued at approximately $407,000.

Other large investors have also recently added to or reduced their stakes in the company. Ameritas Investment Partners Inc. purchased a new stake in Spectranetics Corp during the first quarter valued at $108,000. Bollard Group LLC purchased a new stake in Spectranetics Corp during the first quarter valued at $146,000. Perkins Capital Management Inc. purchased a new stake in Spectranetics Corp during the first quarter valued at $201,000. Janney Montgomery Scott LLC purchased a new stake in Spectranetics Corp during the first quarter valued at $213,000. Finally, Aperio Group LLC purchased a new stake in Spectranetics Corp during the second quarter valued at $261,000. Institutional investors own 91.95% of the company’s stock.

Spectranetics Corp (NASDAQ SPNC) opened at 38.45 on Wednesday. The firm’s 50-day moving average price is $37.28 and its 200-day moving average price is $30.10. Spectranetics Corp has a 52 week low of $19.80 and a 52 week high of $38.55.

Spectranetics Corp (NASDAQ:SPNC) last announced its quarterly earnings data on Thursday, August 3rd. The medical equipment provider reported ($0.56) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by $0.29. The firm had revenue of $74.71 million during the quarter, compared to the consensus estimate of $73.82 million. Spectranetics Corp had a negative return on equity of 194.18% and a negative net margin of 32.93%. The firm’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same period last year, the company earned ($0.35) EPS. Equities analysts expect that Spectranetics Corp will post ($1.16) earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Trexquant Investment LP Takes Position in Spectranetics Corp (SPNC)” was published by Watch List News and is owned by of Watch List News. If you are reading this story on another site, it was illegally copied and republished in violation of U.S. & international trademark and copyright legislation. The correct version of this story can be viewed at https://www.watchlistnews.com/trexquant-investment-lp-takes-position-in-spectranetics-corp-spnc/1493605.html.

Several equities research analysts recently weighed in on SPNC shares. Northland Securities restated a “buy” rating and set a $32.00 price target on shares of Spectranetics Corp in a research report on Friday, April 28th. Needham & Company LLC restated a “buy” rating and set a $34.00 price target (up from $32.00) on shares of Spectranetics Corp in a research report on Friday, April 28th. BidaskClub lowered Spectranetics Corp from a “strong-buy” rating to a “buy” rating in a research report on Saturday, June 10th. ValuEngine upgraded Spectranetics Corp from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. Finally, Zacks Investment Research upgraded Spectranetics Corp from a “sell” rating to a “hold” rating in a research report on Thursday, May 11th. Eleven investment analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $34.69.

Spectranetics Corp Company Profile

The Spectranetics Corporation develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company’s products are used to cross, prepare and treat arterial blockages in the heart and legs and to manage pacemaker and defibrillator cardiac leads.

Want to see what other hedge funds are holding SPNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Spectranetics Corp (NASDAQ:SPNC).

Institutional Ownership by Quarter for Spectranetics Corp (NASDAQ:SPNC)

Receive News & Ratings for Spectranetics Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectranetics Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.